279 related articles for article (PubMed ID: 16596797)
1. Metabolic syndrome: therapeutic considerations.
Grundy SM
Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
[TBL] [Abstract][Full Text] [Related]
2. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
3. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
4. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes.
Stone NJ
Clin Cornerstone; 2006; 8 Suppl 1():S15-20. PubMed ID: 16903165
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome: diagnosis and treatment.
Zieve FJ
Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
[TBL] [Abstract][Full Text] [Related]
6. The metabolic basis of atherogenic dyslipidemia.
Vinik AI
Clin Cornerstone; 2005; 7(2-3):27-35. PubMed ID: 16473258
[TBL] [Abstract][Full Text] [Related]
7. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.
Lechner K; McKenzie AL; Kränkel N; Von Schacky C; Worm N; Nixdorff U; Lechner B; Scherr J; Weingärtner O; Krauss RM
Metab Syndr Relat Disord; 2020 May; 18(4):176-185. PubMed ID: 32119801
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance.
Grundy SM
Clin Cornerstone; 2006; 8 Suppl 1():S21-7. PubMed ID: 16903166
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
Grundy SM
J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
[TBL] [Abstract][Full Text] [Related]
10. Management of dyslipidemia in patients with metabolic syndrome.
Cziraky MJ
J Am Pharm Assoc (2003); 2004; 44(4):478-88; quiz 489-90. PubMed ID: 15372869
[TBL] [Abstract][Full Text] [Related]
11. A constellation of complications: the metabolic syndrome.
Grundy SM
Clin Cornerstone; 2005; 7(2-3):36-45. PubMed ID: 16473259
[TBL] [Abstract][Full Text] [Related]
12. Management issues in the metabolic syndrome.
Deedwania PC; Gupta R
J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome in hypertension: diagnostic and therapeutic implications.
Redon J; Cífková R
Curr Hypertens Rep; 2007 Aug; 9(4):305-13. PubMed ID: 17686382
[TBL] [Abstract][Full Text] [Related]
15. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives.
Chapman MJ
Atherosclerosis; 2003 Nov; 171(1):1-13. PubMed ID: 14642400
[TBL] [Abstract][Full Text] [Related]
16. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
Borgman M; McErlean E
J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
[TBL] [Abstract][Full Text] [Related]
17. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome: a marker of patients at high cardiovascular risk.
Lau DC; Yan H; Dhillon B
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
[TBL] [Abstract][Full Text] [Related]
19. Management of dyslipidemia in the metabolic syndrome.
Tan KC
Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):99-108. PubMed ID: 17584044
[TBL] [Abstract][Full Text] [Related]
20. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
